UMIN ID: UMIN000055430
Registered date:05/09/2024
Confirmation study on the skin-improving effects of plant extract intake
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Healthy Adults |
Date of first enrollment | 2023/09/04 |
Target sample size | 40 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Take supplements containing plant extracts for 12 weeks. Take placebo supplements for 12 weeks. |
Outcome(s)
Primary Outcome | Wrinkle evaluation |
---|---|
Secondary Outcome | Measurement of skin conditions (DermaLab, VISIA-Evolution,questionnaire) |
Key inclusion & exclusion criteria
Age minimum | 40years-old |
---|---|
Age maximum | 59years-old |
Gender | Female |
Include criteria | |
Exclude criteria | 1. Individuals with food allergies. 2. Individuals who are breastfeeding, pregnant, or planning to become pregnant during the study period. 3. Individuals who have received cosmetic medical treatments on the face within the past year or plan to do so during the study period. 4. Individuals currently experiencing moderate to severe atopic dermatitis symptoms, or those using topical treatments frequently on the entire face for atopic dermatitis. 5. Individuals with skin diseases, allergies, or other conditions that may worsen by participating in the study. 6. Individuals with noticeable spots, moles, or birthmarks on the face. 7. Individuals with severe sunburns or those who cannot avoid prolonged outdoor activities or sports. 8. Individuals with a history of major gastrointestinal surgery, or those with respiratory or cardiac disorders. 9. Individuals undergoing or who have undergone hormone replacement therapy for menopausal disorders, unless more than 6 months have passed since the treatment. 10. Individuals who regularly use medications, quasi-drugs, supplements, or health foods that may affect the outcome of the study (e.g., vitamins, hormones, or products claiming skin benefits). 11. Smokers, habitual alcohol consumers, or individuals with extremely irregular eating habits. |
Related Information
Primary Sponsor | Shiba Palace Clinic |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | POLA INC. |
Secondary ID(s) |
Contact
public contact | |
Name | Miwa Kaneko |
Address | 3F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan Japan 105-0013 |
Telephone | 03-5406-1555 |
m_kaneko@mail.souken-r.com | |
Affiliation | SOUKEN Co., Ltd Management Division |
scientific contact | |
Name | Takashi Koikeda |
Address | 6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan Japan |
Telephone | 03-5408-1599 |
jimukyoku@mail.souken-r.com | |
Affiliation | Shiba Palace Clinic Hospital director |